抗精神病剂多巴胺D2亲和和和消极症状在缓解的第一期精神病患者
Franciska de Beer1, Ben Wijnen2, Lotte Wouda1
1University of Groningen, University Medical Centre Groningen, Department of Biomedical Sciences, Groningen, the Netherlands.
Schizophrenia research
|October 19, 2024
概括
抗精神病药物对精神分裂症的负面症状产生影响. 部分激动剂与较少的负面症状有关,与高亲和度对抗剂相比,在患有第一发精神病的患者中.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 负面症状是精神分裂症谱系障碍的核心组成部分.
- 这些症状可以独立出现或受到抗精神病药物的影响.
- 抗精神病药物在多巴胺D2受体亲和力和激动作用方面有所不同,可能会影响负面症状的严重程度.
研究的目的:
- 研究不同类型的抗精神病药物与第一发精神病患者负面症状的严重程度之间的关联.
- 为了在接受部分激动剂,高亲和度D2抗剂和低亲和度D2抗剂治疗的患者中比较负面症状严重程度.
主要方法:
- 一项涉及310名缓解的第一发精神病 (FEP) 患者的研究.
- 通过综合性症状和病史评估以及积极和消极综合征量表来评估负面症状严重程度.
- 线性回归分析具有治疗权重的逆概率,以控制混因素.
主要成果:
- 使用部分激动剂的患者报告的负面症状显著减少,与使用高亲和度D2抗剂的患者相比.
- 一个趋势表明,在接受部分激动剂的患者中,负面症状较少,而非低亲和度D2对抗剂 (p=0.051).
- 较高的抗精神病剂量与增加的负面症状严重程度相关.
结论:
- 在缓解的FEP患者中,部分激动剂与较低的负面症状严重程度有关.
- 高亲和度D2抗剂与更严重的负面症状有关.
- 抗精神病选择可能在控制精神分裂症谱系障碍的负面症状方面发挥作用.
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
159
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
159
Psychosis and Antipsychotic Drugs: Overview
183
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
183
Antipsychotic Drugs: Therapeutic Uses and Side Effects
122
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
122
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
483
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
483
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
227
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
227


